Detalhe da pesquisa
1.
Characterization of discordance between mismatch repair deficiency and microsatellite instability testing may prevent inappropriate treatment with immunotherapy.
J Pathol
; 263(3): 288-299, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38747304
2.
Efficacy of pembrolizumab and biomarker analysis in patients with WGS-based intermediate to high tumor mutational load: results from the Drug Rediscovery Protocol.
Clin Cancer Res
; 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38630551
3.
Patients with Rare Cancers in the Drug Rediscovery Protocol (DRUP) Benefit from Genomics-Guided Treatment.
Clin Cancer Res
; 28(7): 1402-1411, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35046062